| Dr Frances Lauren Rosario, MD, MPH | |
|
Psc 475 Box 1, Fpo, AP 96350-1200 | |
| (315) 243-5505 | |
| Not Available |
| Full Name | Dr Frances Lauren Rosario |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | Psc 475 Box 1, Fpo, Armed Forces Pacific |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689931636 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 0101254543 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Frances Lauren Rosario, MD, MPH Psc 475 Box 1, Fpo, AP 96350-1200 Ph: (315) 243-5505 | Dr Frances Lauren Rosario, MD, MPH Psc 475 Box 1, Fpo, AP 96350-1200 Ph: (315) 243-5505 |
News Archive
A large national study suggests that treating pregnant women for mildly low thyroid function does not improve the IQs of their babies or reduce preterm births or other negative outcomes.
Rutgers Professor Suzie Chen has found that riluzole, a U.S. Food and Drug Administration (FDA) approved drug used to treat Lou Gehrig's disease (ALS), slows the growth of melanoma, the most aggressive form of malignant skin cancer.
Sermo, the world's largest online community for physicians, today announced a Sermo Event™ Report titled "Evolving Trends in CML." The new report measures the impact of ENESTnd trial data on Oncologists' use of Tasigna (Novartis), Sprycel (Bristol Myers-Squibb) and Gleevec (Novartis) in newly diagnosed CML patients and assesses overall trends in CML monitoring and management. While Gleevec will likely remain the #1 treatment, there will be a close race for the runner-up spot amongst second-generation tyrosine kinase inhibitors in the front line setting.
Gene drives are genetic elements - found naturally in the genomes of most of the world's organisms - that increase the chance of the gene they carry being passed on to all offspring, and thus, they can quickly spread through populations. Looking to these natural systems, researchers around the world, including some Wyss Institute scientists, are developing synthetic gene drives that could one day be leveraged by humans to purposefully alter the traits of wild populations of organisms to prevent disease transmission and eradicate invasive species.
› Verified 2 days ago
Dr. Lynn Ann Bailey, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Usnh Yokosuka Japan, Psc 475 Box 1, Fpo, AP 96350 Phone: 011-814-68968728 | |
Katherine Maureen Carlin, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Us Naval Hospital Okinawa, Camp Foster, Fpo, AP 96362 Phone: 315-646-7488 | |
Dr. Thomas Arthur Pluim Ii, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: Psc 490, Box 7668, Fpo, AP 96530 Phone: 671-486-5084 | |
Meghan Leigh Jarman, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Usnh Okinawa, Fpo, AP 96362 Phone: 315-646-7488 | |
Dr. Heather Soloria, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: U.s. Naval Hospital Guam, Psc 455, Fpo, AP 96540 Phone: 671-344-9543 |